Literature DB >> 16837133

Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Luda Diatchenko1, Andrea G Nackley, Gary D Slade, Kanokporn Bhalang, Inna Belfer, Mitchell B Max, David Goldman, William Maixner.   

Abstract

Variations in the gene encoding catechol-O-methyltransferase (COMT) are linked to individual differences in pain sensitivity. A single nucleotide polymorphism (SNP) in codon 158 (val(158)met), which affects COMT protein stability, has been associated with the human experience of pain. We recently demonstrated that three common COMT haplotypes, which affect the efficiency of COMT translation, are strongly associated with a global measure of pain sensitivity derived from individuals' responses to noxious thermal, ischemic, and pressure stimuli. Specific haplotypes were associated with low (LPS), average (APS), or high (HPS) pain sensitivity. Although these haplotypes included the val(158)met SNP, a significant association with val(158)met variants was not observed. In the present study, we examined the association between COMT genotype and specific pain-evoking stimuli. Threshold and tolerance to thermal, ischemic, and mechanical stimuli, as well as temporal summation to heat pain, were determined. LPS/LPS homozygotes had the least, APS/APS homozygotes had average, and APS/HPS heterozygotes had the greatest pain responsiveness. Associations were strongest for measures of thermal pain. However, the rate of temporal summation of heat pain did not differ between haplotype combinations. In contrast, the val(158)met genotype was associated with the rate of temporal summation of heat pain, but not with the other pain measures. This suggests that the val(158)met SNP plays a primary role in variation in temporal summation of pain, but that other SNPs of the COMT haplotype exert a greater influence on resting nociceptive sensitivity. Here, we propose a mechanism whereby these two genetic polymorphisms differentially affect pain perception.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837133     DOI: 10.1016/j.pain.2006.05.024

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  122 in total

1.  Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  Richard Ohrbach; Roger B Fillingim; Flora Mulkey; Yoly Gonzalez; Sharon Gordon; Henry Gremillion; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Joel D Greenspan; Charles Knott; William Maixner; Gary Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 2.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 3.  Central pain mechanisms in chronic pain states--maybe it is all in their head.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

4.  The 2010 Annual Conference of the Canadian Pain Society.

Authors: 
Journal:  Pain Res Manag       Date:  2010 Mar-Apr       Impact factor: 3.037

Review 5.  [Do opioids induce hyperalgesia?].

Authors:  C Zöllner
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

6.  Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors:  O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 7.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

8.  Responding to the challenge of clinically relevant osteopathic research: efficacy and beyond.

Authors:  John C Licciardone
Journal:  Int J Osteopath Med       Date:  2007-03       Impact factor: 2.149

Review 9.  Can quantitative sensory testing move us closer to mechanism-based pain management?

Authors:  Yenisel Cruz-Almeida; Roger B Fillingim
Journal:  Pain Med       Date:  2013-09-06       Impact factor: 3.750

Review 10.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.